Beam Therapeutics, Inc. (BEAM)
26.83
-0.53
(-1.94%)
USD |
NASDAQ |
Dec 15, 16:00
26.83
0.00 (0.00%)
After-Hours: 04:59
Beam Therapeutics Research and Development Expense (Annual): 367.56M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 44.58M |
| Intellia Therapeutics, Inc. | 456.03M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Amicus Therapeutics, Inc. | 109.36M |
| CorMedix, Inc. | 3.942M |